Alacrita Consulting

Recent Posts

Regulatory Contagion: How China's Reforms Are Influencing Drug Development Strategy

Industry Insight September 2025 Regulatory Contagion: How China's Reforms Are Driving a Global Rethink in Drug Development Strategy Efficiency, exemplified by China's model, is emerging as a new axis...
Learn More

Assessing Reasonable Efforts in Biopharmaceutical Licensing Disputes

Learn More

Killer Experiments in Technology Transfer: A Strategic Framework

"In the unforgiving landscape of biotech commercialization, the difference between a promising academic discovery languishing on the shelf and one that commands an eight-figure licensing deal often...
Learn More

The Road to Approval: Navigating the Clinical Drug Development Process

The Road to Approval: Navigating the Clinical Drug Development Process The journey of a drug candidate from preclinical development to New Drug Application (NDA) approval is a critical and complex...
Learn More

Bridging the Gap: How Fractional CMOs Propel Biotech Success

Bridging the Gap: How Fractional CMOs Propel Biotech Success In the dynamic and high-stakes world of biotechnology, early-stage companies navigate a complex landscape of scientific innovation,...
Learn More

EMA Policy 0070: A New Era of Transparency in EU Regulatory Affairs

EMA Policy 0070: A New Era of Transparency in EU Regulatory Affairs The European Medicines Agency (EMA) has ushered in a new era of transparency with the reinstatement of Policy 0070 in late 2023....
Learn More
1

Need biotech consulting support? We can help.

Contact us today to learn how our pharma & biotech consulting expertise can serve your project.

Contact us

Explore our biotech & life science consulting services

© 2009-25 Alacrita Holdings Limited  |   Pharma & Biotech Consulting

Alacrita Consulting 
2 Royal College St
London, UK
NW1 0NH

Registered in England & Wales.
No. 10530608


One Broadway
Floor 14
Cambridge, MA 02142

Registered in Massachusetts.